Zebra Technologies: The Recovery Is Real — the Question Is How Much Is Left

Zebra Technologies has done exactly what investors like to see before deciding a stock "should be in your portfolio": it reported a quarter that blew past estimates, raised guidance, and kept climbing. Shares sit near $351, up roughly 72% over the past four months and about 45% this year, less than 10% below their 52-week high after spending part of the past year near $200. The question worth asking isn't whether the recovery is real. It is. The question is how much of the move is already priced in, and whether the factor stack that drove the rally is still intact or merely coasting on a one-time boost.

The headline numbers from the quarter ended July 4, 2026 look like a compounded-growth machine. Non-GAAP earnings came in at $6.35 a share against a consensus near $4.35, up 76% from a year earlier, and revenue rose 20.4% to $1.56 billion. Management raised its full-year outlook on the strength of that quarter. On the surface, that is a textbook momentum-and-revisions story. Dig under it and the run-rate looks good but more modest than the headline.

Take revenue first. Of that 20.4% reported growth, only 9.2% was organic; roughly 8.7 points came from the Elo Touch acquisition folded into the Connected Frontline segment, plus favorable currency. Same with the earnings beat: the gross margin jumped to 53.0% from 47.6%, but a $73 million IEEPA tariff recovery did much of that work. Strip it out and the adjusted EBITDA margin still expanded, but by roughly two points, not the seven-plus the reported number implies. This is a strong, accelerating enterprise-hardware company riding warehouse automation, healthcare digitization, and machine vision — not quite the 20%-growth, 76%-earnings compounder the first screen suggests.

That distinction matters for the valuation call, because the stock has already re-rated hard off a depressed base. At the current price, Zebra trades around 31 times trailing earnings but closer to 17 times the raised full-year 2026 non-GAAP EPS midpoint of roughly $21.00. Against its automation peers the picture is mid-pack rather than cheap: Cognex trades near 58 times trailing earnings, Roper near 16 times, Honeywell near 8 times. On realized earnings Zebra is not a bargain; on this year's raised guidance it is not a bubble either. What you are paying for is the earnings catching up to a price that already moved.

The factor stack that supports a quality-growth rating is nevertheless genuinely collective, not a one-line score. Growth earns a strong grade on an organic 9.2% advance with an accelerating EPS trajectory; profitability is healthy with a 53% gross margin, roughly 27.7% adjusted EBITDA margin, and an 11.5% return on invested capital. Revisions are the standout — the quarter beat the consensus by more than 40% and guidance was raised — which is what a dynamic system most wants to see. Momentum is confirming but no longer frothy: relative strength has cooled to roughly 55 after the pullback from the high, with the stock still above its 50- and 200-day averages. The weakest links are valuation and balance-sheet safety — 1.9 times net debt to EBITDA, no dividend, and the first-half free cash flow of $361 million that supports a guided $1 billion-plus for the year.

So what does the factor stack say to do? This is a growth-sleeve name, a cyclical-recovery industrial, not a value dip and not a yield payer — it belongs in the quality-growth bucket of a barbell, not the defensive or income sleeve. The rating justifies a buy only on the condition that keeps being a question: whether organic growth and raised guidance keep beating a bar that has already moved up. The next quarter is the honest test. Management guided third-quarter EBITDA margin down to roughly 22% because the tariff recovery does not repeat and memory costs bite, and it flagged a heavy memory-cost headwind for the year. If the organic growth rate holds near the ~7% embedded in the full-year guide and management keeps clearing a raised bar, then ~17 times forward earnings still has room as realized results climb toward the multiple. If the one-time tariff boost flattered the base and revisions stall from here, the easy part of this move is behind it. The winner can keep running inside the process — just don't mistake a completed re-rating for a fresh entry point.